Alimentary Pharmacology & Therapeutics, 2024
I haven't really seen a lot of data that you end up worse off than you were
Still, the broader trend toward earlier initiation reflects a larger paradigm shift in diabetes care, where patients increasingly benefit from the use of GLP-1s early in their treatment journey
Early evidence suggests that individuals using GLP-1s spend significantly less money at the grocery store, shifting their purchasing habits away from snacks, alcohol, and carbohydrates while also increasing demand for high-protein and nutrient-dense foods (e.g., Roe, 2025
PlexusDx provides ongoing support and dose adjustments to manage your unique response
Shatha Taha, GP practitioner specialising in longevity and wellness